PCH
AMED

Polar Capital Holdings’s Amedisys AMED Stock Holding History

Polar Capital Holdings’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,604
Closed -$2.69K – 420
2022
Q2 		$2.69K Sell
25,604
-56,776
-69% -$7.25M 0.02% 269
2022
Q1 		$14.2K Sell
82,380
-18,500
-18% -$2.76M 0.06% 202
2021
Q4 		$16.3K Sell
100,880
-198,277
-66% -$31.9M 0.06% 189
2021
Q3 		$44.6K Buy
299,157
+227,119
+315% +$47.2M 0.18% 112
2021
Q2 		$17.6K Buy
+72,038
New +$18.9M 0.08% 182

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Polar Capital Holdings's AMED Position: Q3 2022 in Review

Polar Capital Holdings sold out of Amedisys (AMED) in Q3 2022, closing a stake of 25,604 shares — an estimated $2.69K sold.

Polar Capital Holdings first reported a position in AMED in Q2 2021 and held it in 5 quarters. The position peaked at $44.6K in Q3 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Polar Capital Holdings reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Polar Capital Holdings sold 25,604 Amedisys shares in Q3 2022, an estimated $2.69K.
  • Polar Capital Holdings first reported a position in Amedisys in Q2 2021 and held it in 5 quarters.
  • Polar Capital Holdings's Amedisys position peaked at $44.6K in Q3 2021.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Polar Capital Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.